Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, and the Plain Language Summary section and the older Revision: v3.6.4 have been removed. This reflects an updated version tag and a change in which content is displayed to users.
    Difference
    0.0%
    Check dated 2026-08-09T09:27:46.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The Ukraine location entry in the Locations list was updated to use a different transliteration (Zaporizhzhya) from Zaporizhzhia. The old entry was removed and a new one added.
    Difference
    0.0%
    Check dated 2026-08-01T23:18:14.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, signaling a newer version of the study detail page. This is a metadata change rather than a substantive update to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T18:37:08.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor update to the content or metadata on the study details page.
    Difference
    0.0%
    Check dated 2026-07-04T14:36:25.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    - Revision updated from v3.6.0 to v3.6.2 on the page, signaling a new release/version behind the scenes. This does not appear to change the visible study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-27T10:36:14.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants'; the page's intervention labeling and related headers were updated (Intervention/Treatment added and Intervention / Treatment removed) as part of Revision v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-12T00:49:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.